Last updated 2026-09-04
- Went public on NASDAQ (AIFF), Feb 2011
- Raised $7.4M Follow-on PO, Feb 2026
- Raised $15M PIPE, Jul 2022
Total raised
$50.8M
Last: Public Offering 2026-04
Stage
Public
Founded
2006
Headcount
17
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences
About
Firefly Neuroscience is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. Its FDA-cleared neurodiagnostic technology enables clinicians to assess how the brain is functioning, not just how a patient feels, using cognitive electrophysiology that combines quantitative EEG (qEEG) and event-related potentials (ERP) in a single, clinic-ready system. The company's platform is built on one of the largest proprietary normative EEG and ERP databases, with over 191,000 recorded sessions. Firefly is used across neurology, psychiatry, TMS, and cognitive care settings to support conditions such as concussion, cognitive decline, depression, anxiety, ADHD, and other brain-based disorders.
Funding history · 13 rounds · $50.8M total
14 events/rounds · $50.8M Total Funding: $46.4M in Public Equity, $4.4M in Debt
May 2026
PIPE
$1.0M
Feb 2026
Follow-on PO
$7.4M
Dec 2025
PIPE
Undisclosed
Aug 2025
Follow-on PO
$2.8M
Jun 2025
PIPE
$1.2M
Dec 2024
Debt Financing
$2.4M
Jul 2024
Follow-on PO
$3.5M
Aug 2022
PIPE
$1.9M
Jul 2022
PIPE
$15.0M
Dec 2021
PIPE
$10.0M
Aug 2021
PIPE
$2.8M
Apr 2021
PIPE
$744K
Apr 2021
Debt Financing
$2.0M
Headcount over time
17 employees (2026-09) · 1 point
Offices
Herzliya, Israel · HQ / main office
Show all offices (2 more)
- Oakville, Canada
- Buffalo, United States
Q&A
- What is Firefly Neuroscience's primary business?
- Firefly Neuroscience is a medical technology company that focuses on objective brain health assessment using its FDA-cleared Brain Network Analytics (BNA™) platform. They develop AI and advanced signal processing technology to record and compare brain function to a large, age-matched database.
- When did Firefly Neuroscience go public?
- Firefly Neuroscience went public on NASDAQ in November 2021.
- What was Firefly Neuroscience's most recent funding event?
- Firefly Neuroscience completed a PIPE funding round in May 2026, raising $1,000,000.
- What was Firefly Neuroscience's most recent acquisition?
- In May 2025, Firefly Neuroscience acquired Evoke Neuroscience for $6,000,000.
- What is the current employee count for Firefly Neuroscience?
- Firefly Neuroscience currently has 11-50 employees.
- What is a recent strategic partnership for Firefly Neuroscience?
- In September 2024, Firefly Neuroscience announced a partnership with Zeto to integrate and distribute its BNA™ Technology with Zeto's FDA-cleared EEG device platform.
- What is Firefly Neuroscience's total funding raised to date?
- Firefly Neuroscience has raised a total of $82,590,000 USD.
- What is a recent development regarding Firefly Neuroscience's technology?
- In March 2026, Firefly Neuroscience progressed toward the development and commercial launch of its Foundation Model of the Human Brain, powered by NVIDIA GPU Acceleration.
- Has Firefly Neuroscience recently expanded its commercial footprint?
- In May 2025, Firefly Neuroscience achieved multi-fold database, IP portfolio, and commercial footprint expansion through the acquisition of Evoke Neuroscience, Inc.
- What is Firefly Neuroscience's market capitalization?
- Firefly Neuroscience has a market capitalization of $11,806,312 USD.
Team · 7
Greg Lipschitz
CEO
Dave DeCaprio
President & COO
Paul Krzywicki
Chief Financial Officer
Gil Issachar
Head of AI and Neuroscience
Arun Menawat
Chairman of the Board
Brian M. Posner
Independent Director
Stella Vnook
Independent Director
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Highlights
1 PatentsVerified
Tags
machine-learningpersonalizationbrain-disorderalzheimers-diseasedecision-supportmappingmental-healthpsychiatrydigital-healthcareneurologypharma-companiesmedical-devicesclinical-trialsimaginghealthcare-providersdegenerative-diseasesartificial-intelligencenon-invasivemedical-cannabisdiagnosticsparkinsonmedical-technologiesdeep-learningdoctorssaas
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | fireflyneuro.com/ |
|---|---|
| linkedin.com/company/2531441 | |
| Crunchbase | crunchbase.com/organization/elminda |
Identifiers & details
| Legal name | Firefly Neuroscience, Inc. |
|---|---|
| Former names | elminda |
| Founded | 2006-1 |
| Employees (exact) | 17 |
| Offices | Oakville; Buffalo |
| Market cap | $11.8M |
| Status reason | Public on NASDAQ on Nov, 2021; |
Acquisitions & public offerings
| Acquired | Date | Amount |
|---|---|---|
| 2025-05 | $6.0M |
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2011-02 | NASDAQ | AIFF |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | fireflyneuro.com |
|---|
Certificate / subdomain footprint
| Subdomains | 6 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513851162 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2006-07-04 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2022 |
| Active charges / liens | 0 |
| Registry events | 1 — other (1) |
| Registered address | משכית 14 הרצליה |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-06 | עדכון חיובים במג~ק |